ANGLE plc: Angle Notice of Interim Results
Notice of Interim Results and WebcastGUILDFORD, SURREY / ACCESSWIRE / August 15, 2023 / ANGLE plc (AIM:AGL), (OTCQX:ANPCY), a world-leading…
0,113€
Echtzeit-Aktienkurs ANGLE plc
Bid:
Ask:
Nachrichten zur ANGLE plc Aktie
Angle PLC Announces Standard Form for Notification of Major Holdings
GUILDFORD, SURREY / ACCESSWIRE / June 27, 2023 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB0034330679Issuer NameANGLE…
ANGLE plc: ANGLE Announces Senior Management Appointments
Brett Swansiger joins as Chief Commercial OfficerKaren Miller PhD joins as Chief Scientific OfficerGUILDFORD, SURREY / ACCESSWIRE / June 5,…
Angle PLC Announces Pharma Services Contract with Artios Pharma
Pharma Services Contract WinParsortix DNA Damage Response Assays developed by ANGLE to be used for exploratory objectives in a Phase…
Angle PLC Announces Board Change - Appointment of New Chairman
GUILDFORD, SURREY / ACCESSWIRE / May 22, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company announces that Garth…
ANGLE plc: ANGLE Presentation Via Investor Meet Company
GUILDFORD, SURREY / ACCESSWIRE / April 21, 2023 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased…
Angle PLC 2022 Pretax Loss Widened; Reports Strong Growth in 1Q
Angle PLC 2022 Pretax Loss Widened; Reports Strong Growth in 1Q...…
Angle PLC Announces Results for the Year Ended 31 December 2022
Preliminary Results for the year ended 31 December 2022FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPSParsortix system substantially out-performs…
ANGLE plc: ANGLE Announces Partnership With BioView
HER2 ASSAY DEVELOPMENT PARTNERSHIP WITH BIOVIEWAgreement with BioView to develop a CTC-based HER2 assayFirst phase expected to generate c. £1.2…
ANGLE plc: ANGLE Parsortix Poster Presented at AACR 2023
PARSORTIX POSTER PRESENTED AT AACR ANNUAL MEETING 2023Study demonstrates the feasibility of combining IF and HER2 FISH analysis with CTCs…
Angle PLC Announces Pharma Services Contract with Crescendo Biologics
Crescendo to use ANGLEs recently launched Portrait Flex Assay in prostate cancer studyGUILDFORD, SURREY / ACCESSWIRE / April 13, 2023…
Angle PLC Announces Notice of Preliminary Results and Webcast
Notice of Preliminary Results and WebcastGUILDFORD, SURREY / ACCESSWIRE / April 3, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid…
Angle PLC Announces Issue of LTIP Options and Share Options
GUILDFORD, UK / ACCESSWIRE / March 10, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, under…
Angle PLC Announces Holding(s) in Company
GUILDFORD, SURREY / ACCESSWIRE / March 9, 2023 / TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS…
Angle PLC Announces Director/PDMR Shareholding
Director/PDMR shareholdingGUILDFORD, SURREY / ACCESSWIRE / February 9, 2023 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company,…